Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol
Crossref DOI link: https://doi.org/10.1007/s13300-018-0546-6
Published Online: 2018-12-06
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schindler, Christoph
Birkenfeld, Andreas L.
Hanefeld, Markolf
Schatz, Ulrike
Köhler, Carsta
Grüneberg, Martin
Tschöpe, Diethelm
Blüher, Matthias
Hasslacher, Christoph
Bornstein, Stefan R.
Text and Data Mining valid from 2018-12-06
Version of Record valid from 2018-12-06
Article History
First Online: 6 December 2018